Menu
Back to User profile » Dr Anthony D D'Urzo
Papers published by Dr Anthony D D'Urzo:
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD
Singh D, D'Urzo AD, Donohue JF, Kerwin EM, Molins E, Chuecos F, Ribera A, Jarreta D
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2835-2848
Published Date: 6 December 2019
Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
D'Urzo AD, Singh D, Donohue JF, Kerwin EM, Ribera A, Molins E, Chuecos F, Jarreta D, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:479-491
Published Date: 26 February 2019
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
D'Urzo AD, Cazzola M, Hanania NA, Buhl R, Maleki-Yazdi MR
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2805-2819
Published Date: 7 September 2018
Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
D’Urzo AD, Kardos P, Wiseman R
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1089-1104
Published Date: 4 April 2018
Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data
D’Urzo AD, Kerwin EM, Chapman KR, Decramer M, DiGiovanni R, D’Andrea P, Hu H, Goyal P, Altman P
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1599-1612
Published Date: 11 August 2015
Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
D’Urzo A
Therapeutics and Clinical Risk Management 2013, 9:341-353
Published Date: 19 August 2013